Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruiting
NCT04398628N/AUpdated Aug 17, 2026
Sponsor: American Thrombosis and Hemostasis Network
Hematologic Disorder · Bleeding Disorder · Connective Tissue Disorder · Hemophilia
United States
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe EczemaRecruiting
NCT06807268Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Eczema
United States, China, Germany, Hungary, Japan +3 more
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their BladderRecruiting
NCT07475806Phase 2Updated Aug 17, 2026
Sponsor: Astellas Pharma Global Development, Inc.
Muscle-invasive Bladder Cancer
United States, Germany, Japan, South Korea, Spain +1 more
Tucatinib Continuation StudyNot Yet Recruiting
NCT07768358Phase 4Updated Aug 17, 2026
Sponsor: Pfizer
HER2-positive Breast Cancer · Cervical Cancer · Biliary Tract Neoplasms · Urothelial Cancer
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or ObesityActive Not Recruiting
NCT07311850Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Obesity and Overweight
United States, Bulgaria, Canada, Czechia, Germany +5 more
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal CancerRecruiting
NCT07392892Phase 2, Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma · Metastatic Gastric Cancer · Gastroesophageal Junction Cancer · Esophageal Adenocarcinoma
United States, China, Israel, Italy, Japan +3 more
Phase 1 Study of PF-08046033 in Advanced Solid TumorsRecruiting
NCT07519655Phase 1Updated Aug 17, 2026
Sponsor: Pfizer
Non-Small-Cell Lung · Esophageal Cancer · Cutaneous Melanoma
United States, Puerto Rico, South Korea
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruiting
NCT06679140Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
COVID-19 SARS-CoV-2 Infection
United States, Argentina, Belgium, Brazil, Bulgaria +14 more
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other TreatmentsRecruiting
NCT05020236Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +21 more
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALLRecruiting
NCT05748171Phase 2Updated Aug 14, 2026
Sponsor: Pfizer
ACUTE LYMPHOBLASTIC LEUKEMIA
Austria, Belgium, Czechia, Denmark, Finland +11 more
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe EczemaNot Yet Recruiting
NCT07765888Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Atopic Dermatitis
A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.Recruiting
NCT06587035N/AUpdated Aug 14, 2026
Sponsor: Pfizer
Dwarfism, Pituitary
India
PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular RosaceaTerminated
NCT06013371Phase 2Updated Aug 14, 2026
Sponsor: Icahn School of Medicine at Mount Sinai
Seborrheic Dermatitis · Papulopustular Rosacea
United States
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsRecruiting
NCT05538130Phase 1Updated Aug 14, 2026
Sponsor: Pfizer
Melanoma · Glioma · Thyroid Cancer · Non-Small Cell Lung Cancer
United States, Australia, Brazil, Canada, China +2 more
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.Recruiting
NCT07028853Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Hormone Sensitive Prostate Cancer · Prostate Cancer · Cancer of the Prostate
United States, Argentina, Australia, Belgium, Brazil +21 more
A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreFRecruiting
NCT07653100Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Respiratory Syncytial Virus (RSV)
India
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderRecruiting
NCT07282665Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Clostridoides Difficile Associated Disease
United States, Argentina, Japan, United Kingdom
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single DoseRecruiting
NCT06866405Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
RSV Infection
United States, Argentina, South Africa, The Gambia
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Recruiting
NCT06629779Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Metastatic Castration-Resistant Prostate Cancer
United States, Argentina, Brazil, Bulgaria, Canada +22 more
A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19Completed
NCT07089680N/AUpdated Aug 14, 2026
Sponsor: Pfizer
Coronavirus Disease 2019 (COVID-19)
South Korea
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of MigraineRecruiting
NCT04743141Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Acute Treatment of Migraine
United States, Poland, Spain
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedRecruiting
NCT07013474Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
COVID-19 Infection
United States, Argentina, Belgium, Brazil, Denmark +13 more
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)Recruiting
NCT06152575Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Multiple Myeloma
United States, Argentina, Australia, Belgium, Brazil +22 more
Randomized Study in Children and Adolescents With Migraine: Acute TreatmentRecruiting
NCT04649242Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Pediatric Migraine
United States, Canada, China, Japan, Mexico +4 more
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia BCompleted
NCT03938792Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Hemophilia A · Hemophilia B
United States, Bulgaria, Canada, China, Croatia +15 more

Previous page Next page